Biomodification of acenocoumarol by bifidobacteria

• Autores: Fragomeno, Melisa; Assad, Sabrina; Mobili, Pablo; Peruzzo, Pablo José; Minnaard, Jessica; Pérez, Pablo Fernando
• Año de publicación: 2021
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: Química; bifidobacteria; biomodification; enzymes; acenocoumarol; probiotic; anticoagulants
• Institución: Universidad Nacional de La Plata

The increased interest of consumers in probiotic foods requires a deeper knowledge on the possible interactions with drugs, because their pharmacological properties could be modified. In this context, these studies are relevant for drugs such as acenocoumarol, whose dosage must be controlled due to, among other factors, food-drug interactions. Acenocoumarol is an oral anticoagulant with a narrow therapeutic range. The aim of the present research is to evaluate, in vitro, the effect of bifidobacteria on acenocoumarol. The drug was incubated with Bifidobacterium bifidum CIDCA 5310 or Bifidobacterium adolescentis CIDCA 5317 in MRS broth at 37◦C for 24 h in anaerobic conditions. The effect of incubation with sterilized spent culture supernatants (SSCS) was also evaluated. Analysis by RP-HPLC showed that both bifidobacterial strains reduced the area of the acenocoumarol peak and two new peaks were evidenced. In addition, a decrease in the intensity of the bands at 1650, 1390 and 1110/cm was observed in the FTIR spectroscopic determinations. Moreover, a new band appeared at 1720/cm. No effect on the drug was observed when incubation was performed with SSCS. The present study showed a significant change in the concentration of the anticoagulant after incubation with bifidobacteria and results are compatible with biomodification of the drug due to enzymatic activity of bifidobacteria.
Centro de Investigación y Desarrollo en Criotecnología de Alimentos
Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas